You just read:

Merrimack Announces a Leading-edge Biomarker-Selected, Multi-Arm Basket Trial that Matches Patients with Most Appropriate Combination Regimens

News provided by

Merrimack Pharmaceuticals, Inc.

19 May, 2016, 07:05 ET